# A Prospective Study on the Therapeutic Outcomes of Mebo and Tantum Verde in Patients With Oral Mucositis

> **NCT07186114** · PHASE3 · COMPLETED · sponsor: **Cairo University** · enrollment: 36 (actual)

## Conditions studied

- Oral Mucositis (Ulcerative) Due to Radiation

## Interventions

- **DRUG:** MEBO Wound Ointment (MEBO)
- **DRUG:** Tantum Verde® mouthwash

## Key facts

- **NCT ID:** NCT07186114
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-01
- **Primary completion:** 2024-12-14
- **Final completion:** 2024-12-14
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07186114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07186114, "A Prospective Study on the Therapeutic Outcomes of Mebo and Tantum Verde in Patients With Oral Mucositis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07186114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*